Prof Richard Sullivan speaks to ecancer about the effect on cancer treatment in the age of COVID-19 and the current worldwide impact.
He explains that at the moment the data coming out is mostly epidemiological and that there just isn't enough data out there on cancer and COVID-19 patients to inform clinical judgements.
Prof Sullivan also discusses the effect of the spread of the virus in low-middle-income countries and believes that the low infection rates are down to the fact that these countries are unable to rigorously test their populations.
He also believes that the impact of the lockdowns on access to cancer treatments could be a major cause for concern.
Prof Sullivan asserts that any piece of information we have on the effect of COVID-19 on cancer patients is essential going forward.